eribulin mesylate
NDC 68083-592, eribulin mesylate, injection, from Gland Pharma Limited.
- Product NDC
- 68083-592
- Status
- Listed
- Labeler
- Gland Pharma Limited
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218047
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68083-592 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ERIBULIN MESYLATE.5 mg/mL
Pharmacologic classes
Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68083-592-01 | 68083059201 | 1 VIAL, SINGLE-DOSE in 1 CARTON (68083-592-01) / 2 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/f57835e2-4c53-4e93-b54b-7d7a5000ae3d
Use it
Look up 68083-592 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68083-592 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68083-592. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.